BioHiTech completes $1.5M financing round

This post was originally published on this site

BioHiTech Global (NASDAQ:BHTG) has completed a $1.5M Series F preferred financing that’s convertible into common stock at a fixed price of $2.10 per share.

As part of the financing, the company issued to the investors a total of 178,597 warrants to purchase common stock at $2.30 per share.

“The completion of this equity infusion helps position BioHiTech to gear up production of its Revolution Series Digesters to fulfill its current book of orders,” said CEO Frank Celli.

BHTG shares are trading up 15% to $1.31 at the time of writing.

Source: dailystockbuzz

Leave a comment

Your email address will not be published. Required fields are marked *